Alternative Splicing in Oncogenic Kinases: From Physiological Functions to Cancer
Open Access
- 5 October 2011
- journal article
- review article
- Published by Hindawi Limited in Journal of Nucleic Acids
- Vol. 2012, 1-14
- https://doi.org/10.1155/2012/639062
Abstract
Among the 518 protein kinases encoded by the human kinome, several of them act as oncoproteins in human cancers. Like other eukaryotic genes, oncogenes encoding protein kinases are frequently subjected to alternative splicing in coding as well as noncoding sequences. In the present paper, we will illustrate how alternative splicing can significantly impact on the physiological functions of oncogenic protein kinases, as demonstrated by mouse genetic model studies. This includes examples of membrane-bound tyrosine kinases receptors (FGFR2, Ret, TrkB, ErbB4, and VEGFR) as well as cytosolic protein kinases (B-Raf). We will further discuss how regular alternative splicing events of these kinases are in some instances implicated in oncogenic processes during tumor progression (FGFR, TrkB, ErbB2, Abl, and AuroraA). Finally, we will present typical examples of aberrant splicing responsible for the deregulation of oncogenic kinases activity in cancers (AuroraB, Jak2, Kit, Met, and Ron).Keywords
This publication has 114 references indexed in Scilit:
- Alternative Splicing Modulates Autoinhibition and SH3 Accessibility in the Src Kinase FynMolecular and Cellular Biology, 2009
- Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growthNature Medicine, 2009
- Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancerNucleic Acids Research, 2008
- Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoformsProceedings of the National Academy of Sciences of the United States of America, 2008
- DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras–ERK pathway, is required for myogenic differentiationThe Journal of cell biology, 2007
- Differential Regulation of B-Raf Isoforms by Phosphorylation and AutoinhibitoryMechanismsMolecular and Cellular Biology, 2007
- Corneal avascularity is due to soluble VEGF receptor-1Nature, 2006
- Receptor Specificity of the Fibroblast Growth Factor FamilyJournal of Biological Chemistry, 2006
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987